FOCUS AREAS
Break Through Cancer’s current focus is on five intractable cancers. These cancers all share common features – a low five-year survival rate, little to no early detection, and a lack of recent progress or innovation in treatment.
Acute Myelogenous Leukemia (AML)
AML begins in the blood-forming cells of the bone marrow and disrupts the body’s ability to form mature, functional blood cells. As a result, initial symptoms of AML include fatigue and anemia. AML is the most common type of acute leukemia in adults and has a five-year survival rate less than 30%. Very often, patients whose initial treatment appears successful will experience a relapse of the disease.
Glioblastoma
Glioblastoma multiforme (GBM) is the most aggressive type of malignant tumor originating in the brain or spinal cord. A GBM makes its own blood supply, which helps it grow and spread rapidly. While GBM can occur at any age, it tends to occur more often in adults between the ages of 45 and 70. The five-year survival rate is 5.5%. GBM occurs in two to three per 100,000 adults per year, and accounts for 52% of all primary brain tumors.
Lung Cancer
ALK-positive (ALK+) lung cancer is a rare subtype of non-small cell lung cancer (NSCLC) driven by genetic alterations in the ALK gene. This subtype disproportionately affects younger individuals and non-smokers. Despite the development of targeted therapies that improve survival, residual disease often persists, leading to relapse. Our research focuses on understanding and eradicating this residual disease to prevent recurrence and improve long-term outcomes.
PancreaticCancer
The pancreas releases enzymes that help with digestion and manufactures hormones that manage blood sugar. Pancreatic cancer begins when abnormal cells in the pancreas grow and divide, forming a tumor. Pancreatic cancer is rarely detected early, as there are typically few symptoms until after the cancer has spread. Pancreatic cancer is the 11th most common diagnosed cancer in the US, and the third leading cause of cancer deaths each year.
BE PART OF THE MISSION
Stay Informed, Make an Impact
Subscribe
Be the first to hear about cutting-edge research, pioneering projects, and the latest advancements in Break Through Cancer science. Sign up to stay informed.
Give
Your contribution fuels groundbreaking research in some of the most challenging cancers. Every gift accelerates progress. For more information please contact Michaela Forand at MF@breakthroughcancer.org or 1-800-757-9881 ext 709.